Cargando…

EGFR modulates complement activation in head and neck squamous cell carcinoma

BACKGROUND: The epidermal growth factor receptor (EGFR) is pivotal for growth of epithelial cells and is overexpressed in several epithelial cancers like head and neck squamous cell carcinoma (HNSCC). EGFR signalling is also involved in diverse innate immune functions in epithelia. We previously fou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abu-Humaidan, Anas H. A., Ekblad, Lars, Wennerberg, Johan, Sørensen, Ole E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020369/ https://www.ncbi.nlm.nih.gov/pubmed/32054454 http://dx.doi.org/10.1186/s12885-020-6615-z

Ejemplares similares

Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma
por: Lindgren, Gustaf, et al.
Publicado: (2014)

Persistent Intracellular Staphylococcus aureus in Keratinocytes Lead to Activation of the Complement System with Subsequent Reduction in the Intracellular Bacterial Load
por: Abu-Humaidan, Anas H., et al.
Publicado: (2018)

EGFR Mutations in Head and Neck Squamous Cell Carcinoma
por: Nair, Sindhu, et al.
Publicado: (2022)

Study of EGFR mutations in head and neck squamous cell carcinomas
por: Kaur, Gurpreet, et al.
Publicado: (2021)

Oxygen Deprivation Modulates EGFR and PD-L1 in Squamous Cell Carcinomas of the Head and Neck
por: Zahnreich, Sebastian, et al.
Publicado: (2021)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
por: Bossi, Paolo, et al.
Publicado: (2016)

EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma
por: Schuler, Patrick J, et al.
Publicado: (2011)

EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
por: Chaudhary, Ritu, et al.
Publicado: (2023)

Complex karyotypes in flow cytometrically DNA-diploid squamous cell carcinomas of the head and neck.
por: Akervall, J., et al.
Publicado: (1998)

Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck
por: Mayer, Arnulf, et al.
Publicado: (2016)

Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma
por: Vatte, Chittibabu, et al.
Publicado: (2017)

EGFR in head and neck squamous cell carcinoma: exploring possibilities of novel drug combinations
por: Rehmani, Hina S., et al.
Publicado: (2020)

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
por: Mineta, H., et al.
Publicado: (1998)

PKM2 Modulation in Head and Neck Squamous Cell Carcinoma
por: Boschert, Verena, et al.
Publicado: (2022)

Cell line dependent expression of EpCAM influences the detection of circulating tumor cells with CellSearch
por: Lindgren, Gustaf, et al.
Publicado: (2017)

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas
por: Mineta, H, et al.
Publicado: (2000)

SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling
por: Barzegar, Mansoureh, et al.
Publicado: (2017)

Effects of culture method on response to EGFR therapy in head and neck squamous cell carcinoma cells
por: Ayuso, Jose M., et al.
Publicado: (2019)

Gold Nanoparticles Enhance EGFR Inhibition and Irradiation Effects in Head and Neck Squamous Carcinoma Cells
por: Kashin, Masahiko, et al.
Publicado: (2020)

Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
por: Xie, Guiqin, et al.
Publicado: (2022)

Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients
por: Ahmad, Fatima M, et al.
Publicado: (2022)

Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer
por: Baba, Yuh, et al.
Publicado: (2012)

MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma
por: Chen, Li-Hsin, et al.
Publicado: (2010)

Confluent tracheal recurrences of head and neck squamous cell carcinoma
por: Bleiberg, Benjamin Aaron, et al.
Publicado: (2019)

New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN)
por: Agulnik, Mark
Publicado: (2012)

EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab
por: Kono, Scott A., et al.
Publicado: (2012)

Correlation between egfr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma
por: Pedicini, Piernicola, et al.
Publicado: (2012)

Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma
por: Michmerhuizen, Nicole L., et al.
Publicado: (2022)

Using chemiluminescence imaging of cells (CLIC) for relative protein quantification
por: Fisher, Jane, et al.
Publicado: (2020)

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
por: Mir, Cristina, et al.
Publicado: (2021)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma
por: Ma, Hailong, et al.
Publicado: (2018)

EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1-TUFM protein complex
por: Lei, Yu, et al.
Publicado: (2016)

Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma
por: Keller, J, et al.
Publicado: (2013)

Influence of EGF and pro-NGF on EGFR/SORTILIN interaction and clinical impact in head and neck squamous cell carcinoma
por: Morisse, Martin, et al.
Publicado: (2023)

Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer
por: Li, Zhipeng, et al.
Publicado: (2018)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ltk33cqg5i4a77b0evlv07qsle